Literature DB >> 30226911

Prevention of Sudden Death in Hypertrophic Cardiomyopathy.

Edmundo Arteaga-Fernández1, Murillo de Oliveira Antunes1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30226911      PMCID： PMC6023624          DOI： 10.5935/abc.20180101

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN： 0066-782X            Impact factor:   2.000


× No keyword cloud information.
  14 in total

1.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

2.  2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Authors:  Bernard J Gersh; Barry J Maron; Robert O Bonow; Joseph A Dearani; Michael A Fifer; Mark S Link; Srihari S Naidu; Rick A Nishimura; Steve R Ommen; Harry Rakowski; Christine E Seidman; Jeffrey A Towbin; James E Udelson; Clyde W Yancy
Journal:  Circulation       Date:  2011-11-08       Impact factor: 29.690

3.  A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD).

Authors:  Constantinos O'Mahony; Fatima Jichi; Menelaos Pavlou; Lorenzo Monserrat; Aristides Anastasakis; Claudio Rapezzi; Elena Biagini; Juan Ramon Gimeno; Giuseppe Limongelli; William J McKenna; Rumana Z Omar; Perry M Elliott
Journal:  Eur Heart J       Date:  2013-10-14       Impact factor: 29.983

4.  Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Pieter A Vriesendorp; Arend F L Schinkel; Max Liebregts; Dominic A M J Theuns; Johan van Cleemput; Folkert J Ten Cate; Rik Willems; Michelle Michels
Journal:  Circ Arrhythm Electrophysiol       Date:  2015-04-28

5.  Benign outcome in a long-term follow-up of patients with hypertrophic cardiomyopathy in Brazil.

Authors:  Edmundo Arteaga; Barbara Maria Ianni; Fábio Fernandes; Charles Mady
Journal:  Am Heart J       Date:  2005-06       Impact factor: 4.749

6.  Independent Assessment of the European Society of Cardiology Sudden Death Risk Model for Hypertrophic Cardiomyopathy.

Authors:  Barry J Maron; Susan A Casey; Raymond H Chan; Ross F Garberich; Ethan J Rowin; Martin S Maron
Journal:  Am J Cardiol       Date:  2015-06-04       Impact factor: 2.778

7.  Clinical course of hypertrophic cardiomyopathy in a regional United States cohort.

Authors:  B J Maron; S A Casey; L C Poliac; T E Gohman; A K Almquist; D M Aeppli
Journal:  JAMA       Date:  1999-02-17       Impact factor: 56.272

8.  2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC).

Authors:  Perry M Elliott; Aris Anastasakis; Michael A Borger; Martin Borggrefe; Franco Cecchi; Philippe Charron; Albert Alain Hagege; Antoine Lafont; Giuseppe Limongelli; Heiko Mahrholdt; William J McKenna; Jens Mogensen; Petros Nihoyannopoulos; Stefano Nistri; Petronella G Pieper; Burkert Pieske; Claudio Rapezzi; Frans H Rutten; Christoph Tillmanns; Hugh Watkins
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

9.  Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Win-Kuang Shen; Tammy S Haas; Francesco Formisano; Mark S Link; Andrew E Epstein; Adrian K Almquist; James P Daubert; Thorsten Lawrenz; Giuseppe Boriani; N A Mark Estes; Stefano Favale; Marco Piccininno; Stephen L Winters; Massimo Santini; Sandro Betocchi; Fernando Arribas; Mark V Sherrid; Gianfranco Buja; Christopher Semsarian; Paolo Bruzzi
Journal:  JAMA       Date:  2007-07-25       Impact factor: 56.272

10.  Prevention of sudden cardiac death with implantable cardioverter-defibrillators in children and adolescents with hypertrophic cardiomyopathy.

Authors:  Barry J Maron; Paolo Spirito; Michael J Ackerman; Susan A Casey; Christopher Semsarian; N A Mark Estes; Kevin M Shannon; Euan A Ashley; Sharlene M Day; Giuseppe Pacileo; Francesco Formisano; Emmanuela Devoto; Aristidis Anastasakis; J Martijn Bos; Anna Woo; Camillo Autore; Robert H Pass; Giuseppe Boriani; Ross F Garberich; Adrian K Almquist; Mark W Russell; Luca Boni; Stuart Berger; Martin S Maron; Mark S Link
Journal:  J Am Coll Cardiol       Date:  2013-04-09       Impact factor: 24.094
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.